Pongchaiyakul Chatlert, Nguyen Nguyen D, Jones Graeme, Center Jacqueline R, Eisman John A, Nguyen Tuan V
Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney, Australia.
J Bone Miner Res. 2005 Aug;20(8):1349-55. doi: 10.1359/JBMR.050317. Epub 2005 Mar 21.
In elderly men and women, asymptomatic vertebral deformity was found to be associated with subsequent risk of symptomatic fractures, particularly vertebral fracture, and increased risk of mortality after a fracture.
Vertebral deformity is associated with an increased risk of fracture and mortality. However, it is unclear whether the three events of vertebral deformity, fracture, and mortality are linked with each other and what role BMD plays in these linkages.
Vertebral deformity was determined from quantitative analysis of thoracolumbar spine X-rays in 300 randomly individuals (114 men and 186 women) 60 years of age (as of mid-1989), who were randomly selected from the prospective Dubbo Osteoporosis Epidemiology Study. Incidence of atraumatic fractures and subsequent mortality were ascertained from 1989 to 2003. Cox's proportional hazards model was used to determine the association between asymptomatic vertebral deformities, osteoporotic fractures, and risk of mortality.
The prevalence of asymptomatic vertebral deformity was 31% in men and 17% in women. During the follow-up period, subjects with vertebral deformity had a significantly higher risk of any fracture than those without vertebral deformity (44% versus 29%; hazards ratio [HR], 2.2; 95% CI, 1.4-3.7), particularly symptomatic vertebral fracture (relative risk [RR], 7.4; 95% CI, 3.2-17.0). Mortality rate was highest after a symptomatic fracture among those with vertebral deformity (HR, 9.0; 95% CI, 3.1-26.0). These associations were independent of age, sex, and BMD.
Vertebral deformity was a strong predictor of subsequent risk of fractures, particularly symptomatic vertebral fracture, and may modify fracture-associated mortality in both elderly men and women.
在老年男性和女性中,发现无症状椎体畸形与随后发生有症状骨折的风险相关,尤其是椎体骨折,并且骨折后死亡风险增加。
椎体畸形与骨折和死亡风险增加相关。然而,椎体畸形、骨折和死亡这三个事件是否相互关联,以及骨密度在这些关联中起什么作用尚不清楚。
从前瞻性的达博骨质疏松症流行病学研究中随机选取300名60岁(截至1989年年中)的个体(114名男性和186名女性),通过对胸腰椎X线进行定量分析来确定椎体畸形。从1989年至2003年确定非创伤性骨折的发生率和随后的死亡率。使用Cox比例风险模型来确定无症状椎体畸形、骨质疏松性骨折和死亡风险之间的关联。
无症状椎体畸形的患病率男性为31%,女性为17%。在随访期间,有椎体畸形的受试者发生任何骨折的风险显著高于无椎体畸形的受试者(44%对29%;风险比[HR],2.2;95%可信区间[CI],1.4 - 3.7),尤其是有症状的椎体骨折(相对风险[RR],7.4;95%CI,3.2 - 17.0)。在有椎体畸形的人群中,有症状骨折后的死亡率最高(HR,9.0;95%CI,3.1 - 26.0)。这些关联独立于年龄、性别和骨密度。
椎体畸形是随后发生骨折风险的有力预测指标,尤其是有症状的椎体骨折,并且可能改变老年男性和女性骨折相关的死亡率。